Fig. 2From: Use of belimumab in treating patients with systemic lupus erythematosus: a single-center, real-world retrospective study(A) SLEDAI-2 K. (B) Physician Global Assessment. (C) SLE responder index-4. *** p < 0.001; **** p < 0.0001Back to article page